The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
about
A review of the efficacy of mitomycin C in glaucoma filtration surgeryWound Healing Modulation in Glaucoma Filtration Surgery-Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I)Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failurePreapplication of mitomycin C for enhanced patency of myringotomy.Preventing myringotomy closure with topical mitomycin C in rats.Inhibition of subglottic stenosis with mitomycin-C in the canine model.Use of mitomycin C for maintaining myringotomy patency.Contact diode laser myringotomy and mitomycin C in children.Preparation and properties of a drug release membrane of mitomycin C with N-succinyl-hydroxyethyl chitosan.Diagnostic pars plana vitrectomy report of a 21-year retrospective studyA meta-analysis of primary external dacryocystorhinostomy with and without mitomycin C.Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysisTrabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.Current approach to postoperative endophthalmitis.Trabeculectomy augmented with mitomycin C application under the scleral flap.Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma.Results of intraoperative mitomycin C application in dacryocystorhinostomy.Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucomaEfficacy of adjunctive mitomycin C in transcanalicular diode laser dacryocystorhinostomy.Trabeculectomy with brief exposure to mitomycin C.Mitomycin-C Application Before versus After Scleral Flap Dissection in Trabeculectomy; a Randomized Clinical Trial.Hypotony maculopathy.Prospective randomized comparison of mitomycin C application in endoscopic and external dacryocystorhinostomyDoes titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?Late-onset Hypotony Maculopathy After Trabeculectomy in a Highly Myopic Patient With Juvenile Open-angle Glaucoma.Improving patient outcomes following glaucoma surgery: state of the art and future perspectives.Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering SurgeriesVictorian trabeculectomy audit.Seven million too many.Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.Histopathologic effects of a low molecular weight heparin on bone healing in rats: a promising adjuvant in dacryocystorhinostomy.Sponge delivery variables and tissue levels of 5-fluorouracil.Incidence of bleb-associated endophthalmitis in the United States.Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up.Efficacy and safety of transconjunctival scleral flap resuturing for hypotony after glaucoma filtering surgery.Protocol for mitomycin C use in glaucoma surgery.Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery.Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.Long-term intraocular pressure control of trabeculectomy and triple procedure in primary open angle glaucoma and chronic primary angle closure glaucoma.
P2860
Q26777325-38C00BEF-97A0-454F-B1C4-62DA5F221DD9Q27021809-4CF31A2F-DE63-404E-A0DC-7697C7EE22BFQ28365765-7261C8A7-574A-49A0-B476-BE304733C029Q30646801-AAF7F6C0-1EF4-4455-8AC5-EFC01A21F630Q30705716-71401EDF-DAC2-4DDB-9EC9-1E9FBA6517ACQ30819796-471ED0E0-C6D1-4EE0-89A4-EEAE7395159EQ30832045-001508EA-CB29-4543-9ABD-B5C3826998DDQ33203726-799D651E-8054-4C21-AFBB-485849EB0E84Q34077412-A27CEA4D-4EA2-4E9E-A06E-E8DABBEEB72BQ34211209-CFCA706F-FB20-4EEB-8EA8-27C76632CA9AQ34484457-AFA1AE61-BB91-4C87-BDE2-92F2793BF390Q34722669-F0FB9F4D-D510-45EC-8A6C-79B869EF57F9Q35063879-36044E32-0B16-4C55-AE67-7A155D8BD4D5Q35298831-FD50B6E3-90E3-4D61-8BB6-73DB22EFD57AQ35304600-7F4BF064-021D-4CB6-AE9F-5CEDE206BEDAQ35308770-E75AF57F-02C3-433C-811E-FFD2EE4BAD6DQ35315538-41C0A3DF-EA19-4CFD-A30D-7075FA5AA510Q35318534-816AB6C3-9D1E-455F-8F76-12A6097BF902Q36143706-7E610777-9778-497B-B23B-2D8EFDEB6AEBQ36639056-C15EB10D-9815-484C-8749-07AB80CB1095Q36696427-CEE34D9D-99A7-41B8-B341-732AEC9437D4Q36837284-D291DE53-1C78-4E5B-BEE0-C1EE3B71BD31Q37083294-A55F0D73-7F33-442F-88AC-2883641C1E24Q37257751-689E1C91-8326-46AB-96D4-C8E70B0441CFQ37737086-AE39A165-60F2-4D9F-B07A-309BB4B540FEQ38212219-48337A5D-D3DD-4AC3-BB7A-524F6AEBFCBEQ38788689-BE7AAE16-1F15-48B6-9B6F-B0606DBE3D04Q38889311-7998A80B-6B1F-45C1-AF18-B86C19AD6AC5Q39717628-C1E69909-FDD2-4553-A6A3-026B0DC33F04Q40074843-56BF6A4C-D65B-4380-9E7F-0F195681CC3DQ40386255-E4383430-DD12-4F65-9B8B-4A64EF0FC217Q41892754-7DFA76CF-14A3-49E7-97E3-D3515CC167BEQ43141637-63E8C942-1D37-425A-A4E2-376B884ECFF5Q44465446-DB839F44-EA8C-44E1-9104-B4BC8B176C84Q46408453-6E8AE2F4-8FC0-4F13-90C6-09D2513FA70BQ51515810-AFF0CDB1-B0CE-4095-A989-CDB879406B51Q53500216-1857C140-56C2-4560-A298-C8215C6D1C21Q53519479-8D5387DA-BF4D-4A89-A6D1-ED02AA6DB460Q53559581-31A0B129-0B27-47A5-A939-FA55547E2CAE
P2860
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
@en
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
@nl
type
label
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
@en
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
@nl
prefLabel
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
@en
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
@nl
P2093
P1433
P1476
The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery.
@en
P2093
Mégevand GS
Scholtz RP
P356
10.1016/S0161-6420(95)31049-4
P577
1995-01-01T00:00:00Z